BIT-314

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBIT-314
Drug Alias NameBIT-314
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus replication inhibitors
TargetsNot applicable
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiotron
China Registration ClassN/A

Develop Information

Active CompaniesBiotron
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A